Literature DB >> 24369898

Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.

Maarten E Witte1, Don J Mahad2, Hans Lassmann3, Jack van Horssen4.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Current treatments are very effective in reducing the neuroinflammatory attack, but fail to significantly halt disease progression and associated loss of neuronal tissue. In recent years, it has become increasingly clear that dysfunctional mitochondria are important contributors to damage and loss of both axons and neurons. Observations in animal and histopathological studies suggest that infiltrating leukocytes and activated microglia play a central role in neuronal mitochondrial dysfunction. This review provides a comprehensive overview on the current knowledge regarding mitochondrial dysfunction in MS. Importantly, more insight into the cause and consequences of impaired mitochondrial function provide a basis for mitochondrial-targeted medicine to combat progressive MS.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  mitochondria; multiple sclerosis; neurodegeneration; neuroinflammation; oxidative stress

Mesh:

Year:  2013        PMID: 24369898     DOI: 10.1016/j.molmed.2013.11.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  80 in total

Review 1.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

2.  Deletion of mitochondrial anchoring protects dysmyelinating shiverer: implications for progressive MS.

Authors:  Dinesh C Joshi; Chuan-Li Zhang; Tien-Min Lin; Anchal Gusain; Melissa G Harris; Esther Tree; Yewin Yin; Connie Wu; Zu-Hang Sheng; Robert J Dempsey; Zsuzsanna Fabry; Shing Yan Chiu
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

3.  Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis.

Authors:  F L Chiang; Q Wang; F F Yu; R S Romero; S Y Huang; P M Fox; B Tantiwongkosi; P T Fox
Journal:  Clin Radiol       Date:  2019-08-14       Impact factor: 2.350

4.  Evidencing different neurochemical profiles between thalamic nuclei using high resolution 2D-PRESS semi-LASER (1)H-MRSI at 7 T.

Authors:  Maxime Donadieu; Yann Le Fur; Sylviane Confort-Gouny; Arnaud Le Troter; Maxime Guye; Jean-Philippe Ranjeva
Journal:  MAGMA       Date:  2016-04-08       Impact factor: 2.310

5.  Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.

Authors:  Maxime Donadieu; Yann Le Fur; Angèle Lecocq; Andrew A Maudsley; Soraya Gherib; Elisabeth Soulier; Sylviane Confort-Gouny; Fanelly Pariollaud; Marie-Pierre Ranjeva; Jean Pelletier; Maxime Guye; Wafaa Zaaraoui; Bertrand Audoin; Jean-Philippe Ranjeva
Journal:  J Magn Reson Imaging       Date:  2016-01-12       Impact factor: 4.813

6.  Transcriptome profiling of expression changes during neuronal death by RNA-Seq.

Authors:  Dharmendra Sharma; Min Soo Kim; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2014-09-25

7.  Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.

Authors:  L Morató; M Ruiz; J Boada; N Y Calingasan; J Galino; C Guilera; M Jové; A Naudí; I Ferrer; R Pamplona; M Serrano; M Portero-Otín; M F Beal; S Fourcade; A Pujol
Journal:  Cell Death Differ       Date:  2015-03-27       Impact factor: 15.828

Review 8.  The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.

Authors:  Rachel R Robinson; Alina K Dietz; Asif M Maroof; Reto Asmis; Thomas G Forsthuber
Journal:  Immunotherapy       Date:  2019-02       Impact factor: 4.196

9.  Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions.

Authors:  Annette Liessem-Schmitz; Nico Teske; Miriam Scheld; Stella Nyamoya; Adib Zendedel; Cordian Beyer; Tim Clarner; Athanassios Fragoulis
Journal:  J Mol Neurosci       Date:  2018-08-23       Impact factor: 3.444

10.  Betaine restores epigenetic control and supports neuronal mitochondria in the cuprizone mouse model of multiple sclerosis.

Authors:  Naveen K Singhal; Sarah Sternbach; Sheila Fleming; Kholoud Alkhayer; John Shelestak; Daniela Popescu; Alyx Weaver; Robert Clements; Brandi Wasek; Teodoro Bottiglieri; Ernest J Freeman; Jennifer McDonough
Journal:  Epigenetics       Date:  2020-03-09       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.